Lung cancer and interstitial lung diseases: the lack of prognostic impact of lung cancer in IPF

被引:0
作者
Loredana Carobene
Donatella Spina
Maria Giulia Disanto
Claudio Micheletto
Maria Antonietta Mazzei
Piero Paladini
Claudia Ghiribelli
Elena Bargagli
Paola Rottoli
机构
[1] Verona Integrated University Hospital,Cardio
[2] University of Verona,Thoracic Department, Respiratory Unit
[3] Siena University Hospital,Pathology Unit
[4] Siena University Hospital,Diagnostic Imaging Unit
[5] Siena University Hospital,Thoracic Surgery Unit
[6] Siena University Hospital,Respiratory Disease and Lung Transplant Unit
来源
Internal and Emergency Medicine | 2022年 / 17卷
关键词
Lung cancer; Interstitial lung disease; Idiopathic pulmonary fibrosis; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
Lung Cancer (LC) is the first cause of death worldwide. Recently increased interest in interstitial lung diseases (ILD) has highlighted an association with lung cancer, offering interesting insights into the pathogenesis of the latter. Describe the association between lung cancer and ILD and evaluate the impact of LC on survival in these populations. We collected clinical, radiological, histologic data of 53 cases of advanced pulmonary fibrosis with lung cancer: 17 with UIP pattern (usual interstitial pneumonia, UIP/IPF-LC) and 36 with non-UIP pattern (ILD-LC). Adenocarcinoma was the most frequent histological subtype of lung cancer in all three groups and in UIP/IPF-LC developed in the lung periphery and in an advanced fibrosis context. Patients with DLCO% < 38% showed survival < 10 months, irrespective of group and development of carcinoma in UIP/IPF does not necessarily affect survival, unlike in SR-ILD. Our results confirm that the oncogenic mechanism is closely linked to fibrotic and inflammatory processes and that the development of carcinoma affects survival in SR-ILD but not in IPF.
引用
收藏
页码:457 / 464
页数:7
相关论文
共 81 条
[1]  
Karampitsakos T(2017)Lung cancer in patients with idiopathic pulmonary fibrosis Pulm Pharmacol Ther 45 1-10
[2]  
Tzilas V(2015)The impact of lung cancer on survival of idiopathic pulmonary fibrosis Chest 147 157-164
[3]  
Tringidou R(2004)The epidemiology of interstitial lung disease and its association with lung cancer Br J Cancer 91 S3-10
[4]  
Steiropoulos P(2014)Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival Respir Med 108 1549-1555
[5]  
Aidinis V(2015)Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis Lung 193 71-77
[6]  
Papiris SA(2017)Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies J Thorac Dis 9 5322-5334
[7]  
Tomassetti S(2016)Clinical features and outcomes of patients with lung cancer as well as combined pulmonary fibrosis and emphysema Mol Clin Oncol 5 273-278
[8]  
Gurioli C(2020)Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis BMC Pulm Med 20 3-2092
[9]  
Ryu JH(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med 370 2083-1068
[10]  
Decker PA(2001)The new World Health Organization classification of lung tumours Eur Respir J 18 1059-656